000023994 000__ 04233cam\a2200625\i\4500 000023994 001__ 23994 000023994 003__ SzGeWIPO 000023994 005__ 20210318104935.0 000023994 008__ 071121s2006 dcu|||||rb||| 00| 0 eng d 000023994 020__ $$a0309100674 000023994 020__ $$z0309655234$$qelectronic book 000023994 020__ $$z9780309655231$$qelectronic book 000023994 020__ $$z9780309100670 000023994 020__ $$z1280447222 000023994 020__ $$z9781280447228 000023994 020__ $$z9786610447220 000023994 020__ $$z6610447225 000023994 035__ $$a(wipo)0 000023994 035__ $$a(OCoLC)66170484 000023994 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL 000023994 043__ $$an-us--- 000023994 050_4 $$aQH447$$b.R43 2006eb 000023994 08204 $$a572.86$$222 000023994 08204 $$a660.65072073$$222 000023994 084__ $$aG 16 MER.R 000023994 090__ $$c26246$$d26242 000023994 1001_ $$aMerril, Stephen A.,$$eauthor. 000023994 24510 $$aReaping the benefits of genomic and proteomic research :$$bintellectual property rights, innovation, and public health /$$cStephen A. Merrill and Anne-Marie Mazza, editors. 000023994 264_1 $$aWashington, D.C. :$$bNational Academies Press,$$cc2006. 000023994 300__ $$axvi, 171 pages ;$$c23 cm 000023994 336__ $$atext$$btxt$$2rdacontent 000023994 337__ $$aunmediated$$bn$$2rdamedia 000023994 338__ $$avolume$$bnc$$2rdacarrier 000023994 500__ $$a"Committee on Intellectual Property Rights in Genomic and Protein Research and Innovation, Board on Science, Technology, and Economic Policy, Committee on Science, Technology, and Law, Policy and Global Affairs, National Research Council of the National Academies." 000023994 5050_ $$aGenomics, proteomics, and the changing research environment -- The U.S. patent system, biotechnology, and the courts -- Trends in the patenting and licensing of genomic and protein inventions and their impact on biomedical research -- Conclusions and recommendations. 000023994 520__ $$aThe patenting and licensing of human genetic material and proteins represents an extension of intellectual property (IP) rights to naturally occurring biological material and scientific information, much of it well upstream of drugs and other disease therapies. This report concludes that IP restrictions rarely impose significant burdens on biomedical research, but there are reasons to be apprehensive about their future impact on scientific advances in this area. The report recommends 13 actions that policy-makers, courts, universities, and health and patent officials should take to prevent the increasingly complex web of IP protections from getting in the way of potential breakthroughs in genomic and proteomic research. It endorses the National Institutes of Health guidelines for technology licensing, data sharing, and research material exchanges and says that oversight of compliance should be strengthened. It recommends enactment of a statutory exception from infringement liability for research on a patented invention and raising the bar somewhat to qualify for a patent on upstream research discoveries in biotechnology. With respect to genetic diagnostic tests to detect patient mutations associated with certain diseases, the report urges patent holders to allow others to perform the tests for purposes of verifying the results. 000023994 650_0 $$aProteomics$$zUnited States$$xPatents. 000023994 650_0 $$aPatent infringement$$zPublic health. 000023994 650_0 $$aPatents$$zPublic health. 000023994 650_0 $$aIntellectual property$$zPublic health. 000023994 650_4 $$aResearch and development (R&D) 000023994 650_6 $$aProtéomique$$zÉtats-Unis$$xBrevets d'invention. 000023994 650_6 $$aPropriété intellectuelle$$zÉtats-Unis. 000023994 650_6 $$aGénomique$$zÉtats-Unis$$xBrevets d'invention. 000023994 651_0 $$aPublic health$$xCommerce$$xLaw and legislation. 000023994 651_0 $$aUnited States$$xCommerce$$xLaw and legislation. 000023994 653__ $$aInnovation 000023994 7001_ $$aMazza, Anne-Marie. 000023994 7001_ $$aCouncil, National Research. 000023994 7001_ $$aMerrill, Stephen A.,$$eeditor. 000023994 7102_ $$aNational Research Council (u.s.).$$bCommittee On Intellectual Property Rights In Genomic And Protein Research And Innovation. 000023994 7102_ $$aNational Research Council (Estados Unidos).$$bCommittee On Intellectual Property Rights In Genomic And Protein Research And Innovation. 000023994 942__ $$cMON$$jG 16 MER.R 000023994 952__ $$w2010-07-02$$p2010-0529$$r29.00$$u40025$$bMAIN$$10$$kG 16 MER.R$$v2010-07-02$$ztagged$$71 000023994 980__ $$aBIB 000023994 999__ $$c26246$$d26246